CLOSTRIDIOIDES DIFFICILE INFECTION
Clinical trials for CLOSTRIDIOIDES DIFFICILE INFECTION explained in plain language.
Never miss a new study
Get alerted when new CLOSTRIDIOIDES DIFFICILE INFECTION trials appear
Sign up with your email to follow new studies for CLOSTRIDIOIDES DIFFICILE INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Sweetener tested to fight dangerous gut infection
Disease control Not yet recruitingThis small, early-stage study is testing whether a common sweetener called xylitol can safely remove C. difficile bacteria from the gut of people with inflammatory bowel disease (IBD). Researchers will give different doses to small groups of participants to find the highest amoun…
Matched conditions: CLOSTRIDIOIDES DIFFICILE INFECTION
Phase: EARLY_PHASE1 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Poop transplants tested as new hope for bowel disease
Disease control Not yet recruitingThis Canadian study is testing whether transferring healthy gut bacteria from donor stool (fecal transplant) can help control ulcerative colitis. Researchers will compare the transplant to a placebo in 85 adults with active disease to see if a larger trial is worthwhile. The goal…
Matched conditions: CLOSTRIDIOIDES DIFFICILE INFECTION
Phase: PHASE1 • Sponsor: University of Alberta • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
Sweetener tested to fight dangerous gut bug in IBD patients
Disease control Not yet recruitingThis study is testing if a common sweetener called xylitol, taken as a daily capsule, can safely remove C. difficile bacteria from the gut of people with inflammatory bowel disease (IBD). The goal is to prevent these patients from developing a serious C. difficile infection. Abou…
Matched conditions: CLOSTRIDIOIDES DIFFICILE INFECTION
Phase: PHASE1 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
New antibiotic battle aims to protect vulnerable gut patients
Disease control Not yet recruitingThis study aims to find out which of two common antibiotics, fidaxomicin or vancomycin, is better at clearing C. difficile bacteria from the gut of people with inflammatory bowel disease (IBD). About 60 adult patients will be randomly assigned to take one of the antibiotics for 1…
Matched conditions: CLOSTRIDIOIDES DIFFICILE INFECTION
Phase: PHASE4 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Mar 09, 2026 14:24 UTC
-
Old drug, new hope: can a gallstone pill stop a dangerous gut infection?
Prevention Not yet recruitingThis early-stage study is testing if adding a bile acid pill called Ursodeoxycholic Acid (UDCA) to standard antibiotic treatment can prevent C. difficile (C. diff) infection from returning. It will enroll 30 high-risk adults who have just been treated for C. diff. The goal is to …
Matched conditions: CLOSTRIDIOIDES DIFFICILE INFECTION
Phase: EARLY_PHASE1 • Sponsor: Medical College of Wisconsin • Aim: Prevention
Last updated Mar 30, 2026 14:32 UTC